The acute-phase protein response to human immunodeficiency virus infection in human subjects. Am. J. Physiol. 276 (Endocrinol. Metab. 39): E1092-E1098, 1999.-Although several studies have shown that asymptomatic human immunodeficiency virus infection elicits an increase in whole body protein turnover, it is not known whether this increased protein turnover includes changes in the kinetics of acute-phase proteins (APPs). To answer this question, we measured 1) the plasma concentrations of four positive (C-reactive protein, ␣ 1 -antitrypsin, haptoglobin, and fibrinogen) and four negative APPs [albumin, high-density lipoprotein (HDL)-apolipoprotein (apo) A1, transthyretin, and retinol-binding protein] and 2) the fractional (FSR) and absolute (ASRs) synthesis rates of three positive and three negative APPs using a constant intravenous infusion of [ 2 H 5 ]phenylalanine in five subjects with symptom-free acquired immunodeficiency syndrome (AIDS) and five noninfected control subjects. Compared with the values of the controls, the plasma concentrations, FSRs, and ASRs of most positive APPs were higher in the AIDS group. The negative APPs had faster FSRs in the AIDS group, there was no difference between the ASRs of the two groups, and only HDL-apoA1 had a lower plasma concentration. These results suggest that symptom-free AIDS elicits an APP response that is different from bacterial infections, as the higher concentrations and faster rates of synthesis of the positive APPs are not accompanied by lower concentrations and slower rates of synthesis of most of the negative APPs.
THE ACUTE-PHASE RESPONSE to the stress of injury or infection is characterized by an increase in whole body protein turnover plus an increased net loss of protein (2, 17) . A fraction of the increase in protein turnover is contributed by components of the body's defense system. These include increased leukocyte proliferation and synthesis of cytokines, immunoglobulins, and positive acute-phase proteins (APPs; see Ref. 7) . Reports of increased protein turnover in humans with symptomfree acquired immunodeficiency syndrome (AIDS, e.g., see Refs. 19 and 26) suggest that infection by the virus, in the absence of clinical signs and symptoms, can elicit changes in protein metabolism. It is not known, however, whether the increased protein turnover in these individuals involves changes in the kinetics of the APPs.
First, it is important to know whether infection by the virus alone elicits an increase in the rate of synthesis of positive APPs, because these proteins serve a variety of important functions related to restoration of homeostasis when the integrity of the animal organism is perturbed by injury or infection (18) . These functions include the containment and destruction of infectious agents by modulating T lymphocyte function and the complement system, the repair of damaged tissues, the protection of healthy tissues, the salvaging of useful components released from damaged tissues, and the indirect alteration of substrate metabolism via the induction of cytokine production (7, 18, 25) .
Second, whereas the plasma concentrations of the positive APPs increase in the acute-phase response to the stress of infection or injury, there is a concomitant decrease in the concentrations of several transport proteins, the so-called negative APPs (3, 6, 7, 18, 25) . The negative APPs are a diverse group that includes albumin, the lipoproteins, transferrin, retinol-binding protein (RBP), and transthyretin, just to name a few (3, 6, 7, 18, 25) . Adequate quantities of these proteins are necessary for survival because they serve a variety of functions that contribute to physiological and metabolic homeostasis through the mechanisms of hemodynamics, transport, and nutrition (7, 25) . A reduction in transport proteins and the secondary pathological and physiological effects of this reduction, such as decreased transport of absorbed nutrients, hormones, and drugs to sites of utilization, are closely associated with higher morbidity and mortality (21) . Hence, the ability to respond with an increase in positive APPs, while maintaining adequate negative APPs, is intrinsically linked to survival of the individual subjected to chronic infection or inflammation.
To determine the effect of human immunodeficiency virus (HIV) infection on the APP response of symptomfree patients, we measured the plasma concentration of four positive and four negative APPs and the rates of synthesis of three positive and three negative APPs in five symptom-free AIDS and five noninfected healthy adult subjects. The plasma flux of phenylalanine was also measured and used as an index of whole body
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protein breakdown rate. The glutathione kinetics of these subjects were also measured; these data have been reported previously (14) .
METHODS

Subjects.
Five male subjects were recruited from HIVinfected patients attending the St. Stephen's Clinic at Chelsea and Westminster Hospital, London. HIV infection was confirmed by enzyme-linked immunosorbent assay. At the time of the study, the subjects had been diagnosed with HIV for 4 Ϯ 1.0 yr. None of the subjects had any signs or symptoms of secondary infections at the time of the study. None had a low-grade fever, and during routine follow-up none developed any specific symptoms. They remained symptom free during the study and for 6 mo after the study. All symptom-free AIDS subjects were on treatment with a combination of zidovudine, zalcitabine, and lamivudine. Five normal healthy subjects (3 males, 2 females) were recruited from the staff of the Clinical Nutrition and Metabolism Unit, University of Southampton, Southampton. They were in good health based on a complete medical history and physical examination. The physical characteristics of all subjects, which have been reported (14) , are shown in Table 1 . They were within the normal range of ideal body weight, and there were no differences between the body mass indexes and plasma volumes of the two groups. The symptom-free AIDS subjects were all weight stable at the time of study, and as a group their weights had increased by an average of 1.9 kg during the 4 Ϯ 1.0-yr interval from diagnosis to the time of this study. The two groups had similar habitual energy and protein intakes as assessed by the 3-day weighed record method ( Table 1 ). The female subjects were studied during the preluteal phase (days 10-12) of their menstrual cycle.
Hematology, Centers for Disease Control classification of HIV-infected subjects. The total white blood cell (WBC) count, lymphocyte profile, and Centers for Disease Control (CDC) classification of the HIV-infected subjects, also reported earlier (14) , are shown in Table 2 . All of the HIV-infected subjects had previous clinical conditions attributed to HIV infection that met the CDC criteria for AIDS (5) . As shown in Table 2 , only one HIV-infected subject had a WBC count below the normal range. One subject had a CD4 ϩ T cell count Ͼ500 cells/µl (CD4 ϩ T cell category 1), three had CD4 ϩ T cell counts Ͼ200 cells/µl (CD4 ϩ T cell category 2), and one had a CD4 ϩ T cell count Ͻ200 cells/µl (CD4 ϩ T cell category 3; see Ref. 5) .
The protocol was approved by the ethical committees of all participating institutions. Signed informed consents of all subjects were obtained after the nature of the study had been explained to them. The symptom-free AIDS subjects were studied at the Chelsea and Westminster Hospital, and the healthy subjects were studied in the metabolic ward of the Clinical Nutrition and Metabolism Unit at the University of Southampton.
Isotope infusion protocol. The rates of synthesis of the APPs were measured from the rates of incorporation of [ 2 H 5 ] phenylalanine into the proteins, using plasma very low density lipoprotein (VLDL)-apolipoprotein (apo) B-100 isotopic enrichment at plateau to represent the isotopic enrichment of the phenylalanine precursor pool from which the liver synthesized the other plasma proteins. A sterile solution of [ 2 H 5 ]phenylalanine (Cambridge Isotope Laboratories, Woburn, MA) prepared in 4.5 g/l NaCl was infused to measure the rates of synthesis of the positive APPs, fibrinogen, haptoglobin, and ␣ 1 -antitrypsin, and the negative APPs, albumin, transthyretin, and high-density lipoprotein (HDL)-apoA1.
After a 10-h overnight fast, the subject's weights and heights were measured, and venous catheters were inserted under local anesthesia in each arm. One catheter was used for infusion of isotope, and the other was used for blood sampling. The hand and forearm with the sampling catheter was wrapped in a heating pad to arterialize venous blood. A sterile solution of [ 2 H 5 ]phenylalanine was infused continuously for 6 h at 4 µmol·kg Ϫ1 ·h Ϫ1 through the catheter in one forearm after a priming dose of 4 µmol/kg was injected. A 6-ml blood sample was drawn before the start of the infusion and at hourly intervals throughout the infusion.
To estimate plasma volume, each subject was administered a dose of 5 mg/kg of Evans Blue dye by intravenous injection, and a blood sample was withdrawn before and 10 min later.
Sample analyses. Blood was drawn in prechilled tubes (containing Na 2 EDTA and a cocktail of sodium azide, merthiolate, and soybean trypsin inhibitor) and immediately centrifuged at 1,000 g for 15 min at 4°C. The plasma was removed and stored at Ϫ70°C for later analysis.
Plasma concentrations of eight proteins [RBP, albumin, HDL-apoA1, transthyretin, C-reactive protein (CRP), ␣ 1 -antitrypsin, haptoglobin, and fibrinogen] were measured by radial immunodiffusion using NL RID kits (The Binding Site, San Diego, CA).
Albumin was extracted from plasma with acidified ethanol, fibrinogen was extracted as fibrin by thrombin precipitation, and VLDL-apoB-100 was separated by ultracentrifugation and isopropanol precipitation. The HDL fraction was separated on a 1.21 g/ml NaBr-EDTA gradient by ultracentrifugation at 450,000 g and 22°C for 16 h (13). Transthyretin, haptoglobin, and ␣ 1 -antitrypsin were isolated from plasma by sequential immunoprecipitation with anti-human transthyretin, haptoglobin, and ␣ 1 -antitrypsin (Behring, Somerville, NJ) as previously described (15) . The immunoprecipitates and protein precipitates were subjected to SDS-gel electrophoresis to separate the particular protein from its specific antibody and to separate apoA1 from HDL. A pure standard of the protein (Sigma, St. Louis, MO) and low-molecularweight standards (Bio-Rad Laboratories, Richmond, CA) were also included in the gel (15) . After staining with Coomassie brilliant blue dye, the bands corresponding to the protein standard were cut out and washed several times. The dried protein precipitates and gel bands were hydrolyzed in 6 mol/l HCl at 110°C for 12 h. Amino acids released from hydrolysis of the proteins and plasma amino acids were extracted by cation exchange chromatography, and the tracerto-tracee ratio of the phenylalanine was determined by negative chemical ionization gas chromatography-mass spectrometry on a Hewlett-Packard 5988A GC-MS (Palo Alto, CA). The amino acid was converted to the n-propyl ester heptafluorobutyramide derivative, and the phenylalanine 
where IRt 6 Ϫ IRt 4 is the increase in isotope ratio of albumin (or transthyretin, apoA1, fibrinogen, haptoglobin, ␣ 1 -antitrypsin)-bound phenylalanine over the period t 6 (time 6 h) to t 4 (time 4 h) of the infusion, and IR pl is the plateau isotope ratio of VLDL-apoB-100-bound phenylalanine. In this calculation, the plateau tracer-to-tracee ratio of VLDL-apoB-100-bound phenylalanine in plasma is assumed to represent the tracerto-tracee ratio of the intrahepatic phenylalanine pool from which albumin (and the other APPs) is synthesized (13) . Steady-state tracer-to-tracee ratio was obtained by finding the average of the individual tracer-to-tracee ratio values after the tracer-to-tracee ratio-time curve reached a plateau. Plateau was defined as follows: the tracer-to-tracee ratio at each time point was normalized to the last value obtained at the end of the 6-h infusion. These values were then analyzed by linear regression against time of infusion as the independent variable. Plateau was verified when the slope of the normalized tracer-to-tracee ratio/time line was not significantly different from zero. The criterion was made stringent by setting the level of significance at P Ͻ 0.25. The absolute intravascular synthesis rate (iv ASR) of albumin (or transthyretin, HDL-apoA1, fibrinogen, haptoglobin, ␣ 1 -antitrypsin) was estimated as the product of FSR and the intravascular mass of the protein
where the intravascular mass of a protein is the product of the plasma volume and the plasma concentration of the particular protein.
The plasma volume of each subject was calculated by the dye dilution technique as described by Gibson and Evans (9) .
The standard steady-state equation was used to calculate the flux of phenylalanine in the circulation Data are expressed as means Ϯ SE for each group. Differences between groups were detected by the nonpaired t-test. A probability of 5% (P Ͼ 0.05) was assumed to represent statistical significance.
RESULTS
The net tracer-to-tracee molar ratio (mol% above baseline) of free plasma phenylalanine reached a steady state after 2 h of the isotope infusion in all four studies; hence, the flux of phenylalanine was calculated using the average tracer-to-tracee ratio during the last 4 h of the tracer infusion (Fig. 1) . The tracer-to-tracee ratio of VLDL-apoB-100-bound phenylalanine reached a steady state after 3 h of the isotope infusion in all four studies (Fig. 1) . Hence, the FSRs and APPs were calculated from the rate of incorporation of labeled phenylalanine in each protein during the last 2 h of the tracer infusion.
The positive APPs. The symptom-free AIDS group had significantly higher plasma CRP (P Ͻ 0.01), fibrinogen (P Ͻ 0.05), and haptoglobin (P Ͻ 0.01) concentrations than the control group (Tables 3 and 4 ). There was no difference, however, in the plasma concentration of ␣ 1 -antitrypsin between the two groups. The larger plasma pools of fibrinogen and haptoglobin in the symptom-free AIDS group were associated with faster FSRs (P Ͻ 0.05; P Ͻ 0.01) of the proteins in this group than in the control group (Table 4) . Similarly, the ASRs of fibrinogen and haptoglobin were significantly greater (P Ͻ 0.01) in the symptom-free AIDS group than in the control group. There was no difference, however, between the groups in either FSR or ASR of ␣ 1 -antitrypsin.
The negative APPs. There was no difference in the plasma concentration of RBP, albumin, or transthyretin between the two groups (Tables 3 and 5 ). The plasma concentration of HDL-apoA1 was, however, lower in the symptom-free AIDS group than in the control group (P Ͻ 0.05). The FSRs of albumin, transthyretin, and HDL-apoA1 were significantly faster (P Ͻ 0.05) in the HIV-infected group than in the control group (Table 5) . Despite the faster FSRs of the symptomfree AIDS group, there was no difference in the ASRs of albumin, transthyretin, and HDL-apoA1 compared with the rates of the control group. There was, however, a trend toward a faster ASR in albumin and transthyretin in the symptom-free AIDS group.
The plasma flux of phenylalanine was significantly faster (P Ͻ 0.05) in the symptom-free AIDS group (64 Ϯ 6 µmol · kg Ϫ1 · h Ϫ1 ) compared with the control group (48 Ϯ 2 µmol · kg Ϫ1 · h Ϫ1 ).
DISCUSSION
Although there have been reports of increased whole body protein turnover rates in asymptomatic HIVinfected and AIDS patients (e.g., see Refs. 19 and 26), it is not known whether this increased protein turnover rate includes changes in the rates of synthesis of the APPs. This study aimed to determine the effect of infection by the HIV alone on the APP response in AIDS patients who were free of signs and symptoms of secondary infections or any other AIDS-related complications. The findings show that the plasma concentrations and both the FSRs and ASRs of most of the positive APPs are considerably higher in symptom-free AIDS individuals than in noninfected healthy controls. Although the negative APPs had faster FSRs in the symptom-free AIDS group, there was no difference in the ASRs of these proteins between the two groups. In the symptom-free AIDS group, one of the negative APPs, HDL-apoA1, had a lower plasma concentration despite a faster FSR. These results suggest that HIV infection does elicit an APP response. However, the response is atypical, as the higher concentrations and faster rates of synthesis of the positive APPs are not accompanied by lower concentrations and slower rates of synthesis of most of the negative APPs.
Although the APP response to bacterial infections has been well established in the literature (e.g., see Refs. 3 and 6), very few studies have investigated the response to viral infections. In the typical APP response to the stress of a bacterial infection, the plasma concentrations of the positive APPs increase, whereas the concentrations of the negative APPs decrease (2, 4, 14, 20) . On average, there is a two-to fourfold increase in the plasma concentration of most positive APPs in response to injury or infection (3, 6, 7, 18, 25) . Concomitantly, the plasma concentrations of the negative APPs decrease by as much as 25-75% (3, 6, 7, 18, 25) . It is not known, however, whether this APP response can be elicited by viral infections, especially chronic subclinical viral infections such as HIV infection. The limited data available in the literature suggest that, whereas acute viral infections can elicit an APP response, chronic subclinical viral infections cannot. For example, Miwata et al. (22) reported higher plasma concentrations of the positive APPs CRP and serum amyloid A in children infected with measles, varicella, rubella, and echo-30 meningitis but not in children with chronic hepatitis B and C. In the present study, however, the higher plasma concentrations of the positive APPs, CRP, fibrinogen, and haptoglobin, and the faster FSRs and ASRs of fibrinogen and haptoglobin suggest that presence of the virus does elicit an APP response in symptom-free AIDS subjects. However, the failure to elicit any change in ␣ 1 -antitrypsin concentration and rate of synthesis suggests that the HIV-induced APP response does not include all of the positive APPs. Similarly, Miwata et al. reported no changes in the plasma concentrations of two, ␣ 1 -acid glycoprotein and ␤ 2 -microglobulin, out of four positive APPs in response to measles, varicella, rubella, and echo-30 meningitis infections. Together, the findings of Miwata et al. and our present data suggest that HIV infection elicits an APP response that is similar to that elicited by symptomatic viral infections. The increased FSRs and ASRs of fibrinogen and haptoglobin suggest that the larger plasma pools of the positive APPs were due to stimulated rates of synthesis. At present, we are not aware of any other kinetic study of the APPs in symptom-free AIDS patients, and there are only a few studies in the literature that have looked at changes in the plasma concentrations of the APPs (11, 12, 23) . In agreement with our present findings, Grunfeld et al. (11) reported higher plasma concentrations of CRP in a similar group of symptomfree AIDS patients compared with the plasma concentrations of a group of healthy controls. There was, however, no difference in the plasma concentration of haptoglobin between the two groups. In another study, Monnet et al. (23) reported that one (␤ 2 -microglobulin) of three positive APPs (␤ 2 -microglobulin, CRP, and ␣ 1 -antitrypsin) had a higher plasma concentration in a group of symptom-free AIDS patients. The findings of these two studies, together with our present data, demonstrate that infection by the HIV elicits an APP response even in the absence of secondary infections. However, the response does not include all of the positive APPs and is of a lesser magnitude than that observed in response to severe injury or bacterial infection (3, 6, 7, 18, 25) .
Our data show that there were no differences in the plasma concentrations of the negative APPs, albumin, RBP, and transthyretin between the symptom-free AIDS group and the noninfected control group. The exception was HDL-apoA1, which had a lower plasma concentration in the symptom-free AIDS group. These findings are in agreement with those of Hommes et al. (12) , who reported no difference in the plasma concentrations of albumin, RBP, or transferrin between a group of asymptomatic HIV-infected patients and a group of control subjects. Our data do not agree, however, with the findings of Monnet et al. (23) that plasma RBP and transthyretin concentrations were significantly lower in a group of symptom-free AIDS patients than in a group of noninfected control subjects. The negative APPs albumin, transthyretin, and HDLapoA1 had faster FSRs in the symptom-free AIDS group than in the control group, and, although the differences between the ASRs of the two groups were not statistically significant, there was a trend toward faster ASRs for albumin and transthyretin in the symptom-free AIDS subjects. These findings suggest that the symptom-free AIDS group was turning over these proteins at a faster rate to maintain the plasma pool and hence the availability of the proteins.
The symptom-free AIDS group had a significantly lower plasma HDL-apoA1 concentration despite a faster FSR and an ASR that was almost identical to that of the control group. This finding is in agreement with that of Grunfeld et al. (11) , who reported lower plasma concentrations of HDL-apoA1 in a similar group of symptomfree AIDS patients than in healthy controls. Because the pool size of a plasma protein is determined by the balance between its rates of synthesis and catabolism or loss, our present findings suggest that the lower HDL-apoA1 concentrations of the symptom-free AIDS subjects result from faster rates of catabolism, or loss from the intravascular space, relative to the rates of It is generally accepted that, in the presence of injury and infection, protein metabolism accommodates the demands related to increased lymphocyte proliferation and synthesis of cytokines, immunoglobulins, and positive APPs by redistribution of amino acid precursors, hence protein synthetic activity, away from the synthesis of muscle and the negative APPs (7) . Although the increased synthesis of positive APPs necessary to mount a successful response to stress obviously is beneficial, the decreased syntheses of the negative APPs, most of which play major roles in the transport of nutrients, hormones, metabolites, and drugs, are equally important. For example, a reduction in negative APPs, which are responsible for the transport of absorbed nutrients to sites of utilization, will further impede nutrient utilization. Our present data demonstrate that symptom-free AIDS subjects are capable of maintaining a higher plasma concentration and rate of synthesis of most positive APPs without a corresponding decrease in the plasma concentration of most negative APPs. Because HIV-infected individuals are prone to malnutrition, it is imperative that they maintain adequate quantities of transport proteins. Hence, the ability to mount a positive APP response and also to maintain higher rates of synthesis of negative APPs may represent a beneficial adaptation by the individual subjected to infection by the virus.
On the other hand, it is possible that subclinical infections, such as the HIV infection, are incapable of eliciting a full-blown APP response. For example, whereas plasma concentration of interleukin (IL)-6, the primary mediator of the APP response, is 16 times higher in HIV-infected subjects with secondary infections (4), Hommes et al. (12) reported only a doubling of IL-6 in asymptomatic HIV-infected subjects, to a value that was still within the normal range. Secondly, in severe injury and acute infections, plasma CRP concentration can increase up to 100-fold or more (7, 18) . In the present study, however, whereas CRP concentration was significantly higher in the symptom-free AIDS subjects, it was only nine times the control value. Together these findings (4, 12) plus our present data suggest that the atypical APP response observed in the present study may be due to the inability of HIV infection to stimulate IL-6 production, or the production of other cytokines and factors necessary to elicit an intense APP response.
Finally, although in the past it was believed that the lower concentration of the negative APPs induced by stressed states was due to a reduced rate of synthesis of these proteins (1), the faster FSRs of the three negative APPs in the present study were not surprising. This finding is in agreement with our previous finding that the lower albumin concentration of marasmic children was accompanied by a faster albumin FSR when the children were also stressed by infections compared with when their infections were cleared (24) . Similarly, Mansoor et al. (20) reported that the hypoalbuminemia of head trauma subjects was accompanied by a 60% increase in the rate of albumin synthesis during the acute response to head trauma. Together, these findings suggest that the stress of infection, inflammation, and injury stimulates and does not suppress the rate of synthesis of albumin. In all likelihood, the concentrations of albumin and other negative APPs decrease precipitously in response to infections, severe trauma, and inflammation because of an increased transcapillary escape rate and an increased catabolic rate (8, 10) . More recently, we have reported that turpentine inflammmation induced marked increases in albumin FSR in both protein-malnourished and healthy pigs (16) . Whereas the stimulation of albumin FSR was associated with an increase in albumin concentration in the healthy pigs, there was, however, a precipitous fall in plasma albumin concentration in the proteinmalnourished pigs, suggesting that the turpentine inflammation was sufficient to elicit an increase in albumin catabolism or intravascular loss in the proteinmalnourished pigs but not in the healthy pigs (16) . It is therefore possible that symptom-free AIDS subjects are capable of maintaining normal plasma concentrations of negative APPs because the stress of the infection is not of sufficient magnitude to elicit an increase in albumin catabolism or intravascular loss.
